We Think Bioceltix (WSE:BCX) Can Afford To Drive Business Growth
Dec 11
Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedMar 02, 2026
DataAggregated Company Financials
Companies13
- 7D0.8%
- 3M2.7%
- 1Y-3.5%
- YTD6.3%
Over the last 7 days, the Biotech industry has remained flat. As for the longer term, the industry has declined 4.1% in the last year. Looking forward, earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 02 Mar 2026 | zł2.0b | zł429.9m | -zł152,630,978.00 | 67.6x | -13.3x | 4.7x |
| Wed, 28 Jan 2026 | zł2.1b | zł427.5m | -zł155,672,238.00 | 46.8x | -13.2x | 4.8x |
| Fri, 26 Dec 2025 | zł1.8b | zł427.5m | -zł155,672,238.00 | 46.2x | -11.7x | 4.3x |
| Sun, 23 Nov 2025 | zł1.8b | zł427.7m | -zł158,415,044.00 | 45.9x | -11.6x | 4.3x |
| Tue, 21 Oct 2025 | zł1.9b | zł394.6m | -zł166,699,765.00 | 41.6x | -11.6x | 4.9x |
| Thu, 18 Sep 2025 | zł2.0b | zł400.7m | -zł143,324,812.00 | 41.1x | -13.6x | 4.9x |
| Sat, 16 Aug 2025 | zł2.1b | zł402.5m | -zł140,521,881.00 | 47.2x | -14.8x | 5.2x |
| Mon, 14 Jul 2025 | zł2.0b | zł401.8m | -zł140,766,468.00 | 33x | -14.5x | 5.1x |
| Wed, 11 Jun 2025 | zł2.1b | zł398.2m | -zł145,311,212.00 | 49x | -14.3x | 5.2x |
| Fri, 09 May 2025 | zł2.1b | zł425.0m | -zł113,104,193.00 | 53.9x | -18.5x | 4.9x |
| Sun, 06 Apr 2025 | zł1.9b | zł438.8m | -zł95,426,193.00 | 31x | -20.2x | 4.4x |
| Tue, 04 Mar 2025 | zł2.0b | zł438.6m | -zł94,885,631.00 | 29.8x | -21.6x | 4.7x |
| Thu, 30 Jan 2025 | zł2.0b | zł408.7m | -zł84,434,269.00 | 42.2x | -23.4x | 4.8x |
| Sat, 28 Dec 2024 | zł1.8b | zł408.7m | -zł84,434,269.00 | 39.5x | -21.9x | 4.5x |
| Mon, 25 Nov 2024 | zł1.9b | zł407.6m | -zł85,383,772.00 | 39.2x | -22.2x | 4.7x |
| Wed, 23 Oct 2024 | zł2.1b | zł438.7m | -zł64,845,969.00 | 62.4x | -33x | 4.9x |
| Fri, 20 Sep 2024 | zł2.1b | zł442.8m | -zł53,453,784.00 | 62.8x | -39.5x | 4.8x |
| Sun, 18 Aug 2024 | zł2.2b | zł443.9m | -zł63,570,104.00 | 74x | -34x | 4.9x |
| Tue, 16 Jul 2024 | zł2.1b | zł444.2m | -zł64,230,755.00 | 71x | -33.1x | 4.8x |
| Thu, 13 Jun 2024 | zł2.0b | zł439.7m | -zł90,277,755.00 | 71x | -22.2x | 4.6x |
| Sat, 11 May 2024 | zł2.3b | zł441.3m | -zł90,006,665.00 | 56.2x | -25.2x | 5.1x |
| Mon, 08 Apr 2024 | zł2.2b | zł432.0m | -zł73,964,007.00 | 61.4x | -29.7x | 5.1x |
| Wed, 06 Mar 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 56.7x | -30.9x | 5x |
| Fri, 02 Feb 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 85.2x | -40.4x | 5.4x |
| Sun, 31 Dec 2023 | zł2.7b | zł499.9m | -zł66,755,911.00 | 87x | -40.6x | 5.4x |
| Tue, 28 Nov 2023 | zł2.6b | zł498.2m | -zł58,578,911.00 | 96.7x | -44.2x | 5.2x |
| Thu, 26 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 46.3x | -44x | 5.2x |
| Sat, 23 Sep 2023 | zł2.8b | zł518.5m | -zł61,744,678.00 | 50.4x | -44.9x | 5.4x |
| Mon, 21 Aug 2023 | zł2.8b | zł520.3m | -zł43,292,668.00 | 51.6x | -64.5x | 5.4x |
| Wed, 19 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 54.3x | -68.5x | 5.6x |
| Fri, 16 Jun 2023 | zł2.9b | zł517.3m | -zł42,548,721.00 | 62.4x | -67.5x | 5.6x |
| Sun, 14 May 2023 | zł2.9b | zł520.8m | -zł42,603,826.00 | 65.9x | -69.2x | 5.7x |
| Tue, 11 Apr 2023 | zł2.8b | zł492.9m | -zł11,631,449.00 | 59.7x | -242.9x | 5.7x |
| Thu, 09 Mar 2023 | zł2.9b | zł488.6m | -zł16,165,349.00 | 65.1x | -178.4x | 5.9x |
Price to Earnings Ratio
-178.4x
Current Industry PE
- Investors are relatively neutral on the Polish Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 4.2% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 0.24% | |
| Healthcare | 0.55% | |
| Biotech | 0.77% | |
| Biotech | 0.77% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SVE Synthaverse | zł3.76 | 2.2% +zł5.7m | -21.1% | PE59.8x | |
| PTG Poltreg | zł25.80 | 4.0% +zł4.7m | -29.5% | PB2.4x | |
| URT Urteste | zł56.00 | 3.7% +zł2.8m | -38.5% | PS43.9x | |
| MAB Mabion | zł8.23 | 1.5% +zł1.9m | -22.4% | PS9x | |
| TEC Tecnovatica | zł0.49 | 28.9% +zł1.2m | -37.7% | PE75.5x |